Genzyme On Carl Icahn's Radar

This is making the wires quickly... Carl Icahn has accumulated a few shares (1,518,463 to be exact) in Genzyme (Ticker: GENZ) from today's SEC filing. This guy is usually not a passive investor so it'll be interesting to see what he plans to do with his shares in Genzyme. He's been focusing on the biotech sector recently and has forced Medimmune and Biogen Idec (Ticker: BIIB) to put themselves up for sale. Genzyme is in much stronger position than those companies with earnings projected to growth at 20%+ for the next couple of years. Genzyme stock is cheap and now Carl Icahn wants to maximize its value. With this news, Genzyme will pop tomorrow.